Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized vs Standard Hydration for CI-AKI Prevention
NCT02225431Phase 4Completed
- Sponsor
- Ospedale Misericordia e Dolce
- Start
- Sep 2012
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium chloride in contrast-induced acute kidney injury (CI-AKI) (2 arms), sponsored by Ospedale Misericordia e Dolce. Primary endpoint: Contrast-Induced Acute Kidney Injury at 1 day. Started Sep 2012; status: completed.
02
Drugs
sodium chloride
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT02225431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225431.